{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:03:35Z","timestamp":1767146615366,"version":"build-2238731810"},"reference-count":71,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.lpm.2015.07.005","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T02:45:50Z","timestamp":1439347550000},"page":"779-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dur\u00e9e optimale du traitement anticoagulant au d\u00e9cours d\u2019une embolie pulmonaire"],"prefix":"10.1016","volume":"44","author":[{"given":"C\u00e9cile","family":"Tromeur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Couturaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2 Suppl.","key":"10.1016\/j.lpm.2015.07.005_bib0360","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"43","key":"10.1016\/j.lpm.2015.07.005_bib0365","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2015.07.005_bib0370","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0140-6736(92)93285-U","article-title":"Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism","volume":"340","author":"Research Committee of the British Thoracic Society","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2015.07.005_bib0375","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1055\/s-0038-1649783","article-title":"Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep-vein thrombosis","volume":"74","author":"Levine","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2015.07.005_bib0380","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1056\/NEJM199506223322501","article-title":"A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism","volume":"332","author":"Schulman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0385","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJM199210153271604","article-title":"Deep-vein thrombosis and the incidence of subsequent symptomatic cancer","volume":"327","author":"Prandoni","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0390","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"362","author":"Baglin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2015.07.005_bib0395","first-page":"743","article-title":"Comparison of 1 month versus 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor","volume":"2","author":"Kearon","year":"2004","journal-title":"JTH"},{"issue":"2","key":"10.1016\/j.lpm.2015.07.005_bib0400","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0038-1648837","article-title":"Low-molecular-weight heparin versus warfarin the prevention of recurrence after deep-vein thrombosis","volume":"72","author":"Pini","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2015.07.005_bib0405","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","article-title":"A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism","volume":"340","author":"Kearon","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0410","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.103.20.2453","article-title":"Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep-vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep-vein thrombosis","volume":"103","author":"Pinede","year":"2001","journal-title":"Circulation"},{"issue":"7595","key":"10.1016\/j.lpm.2015.07.005_bib0415","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bmj.39098.583356.55","article-title":"Anticoagulation for three versus six months in patients with deep-vein thrombosis or pulmonary embolism, or both: randomised trial","volume":"334","author":"Campbell","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2015.07.005_bib0420","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-139-1-200307010-00008","article-title":"Extended oral anticoagulant therapy after a first episode of pulmonary embolism","volume":"139","author":"Agnelli","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0425","doi-asserted-by":"crossref","first-page":"d3036","DOI":"10.1136\/bmj.d3036","article-title":"Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants\u2019 data from seven trials","volume":"342","author":"Boutitie","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2015.07.005_bib0430","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJM200107193450302","article-title":"Three months versus one year of oral anticoagulant therapy for idiopathic deep-vein thrombosis","volume":"345","author":"Agnelli","year":"2001","journal-title":"N Eng J Med"},{"issue":"1","key":"10.1016\/j.lpm.2015.07.005_bib0435","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.2015.7046","article-title":"Two years versus six months of oral anticoagulation after a first episode of unprovoked pulmonary embolism. The PADIS-PE multicenter, double-blind, randomized, trial","volume":"314","author":"Couturaud","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2015.07.005_bib0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long-term clinical course of acute deep venous thrombosis","volume":"125","author":"Prandoni","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0445","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinte.160.6.761","article-title":"Predictors of recurrence after deep-vein thrombosis and pulmonary embolism: a population-based cohort study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0450","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.2000.18.17.3078","article-title":"Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis","volume":"18","author":"Hutten","year":"2000","journal-title":"J Clin Oncology"},{"key":"10.1016\/j.lpm.2015.07.005_bib0455","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lpm.2015.07.005_bib0460","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0465","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.critrevonc.2008.12.004","article-title":"2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group","volume":"73","author":"Farge","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.lpm.2015.07.005_bib0470","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jmv.2009.12.002","article-title":"Guidelines for good clinical practice: prevention and treatment of venous thromboembolism in medical patients","volume":"35","author":"Mismetti","year":"2010","journal-title":"J Mal Vasc"},{"issue":"1","key":"10.1016\/j.lpm.2015.07.005_bib0475","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/M14-1275","article-title":"D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study","volume":"162","author":"Kearon","year":"2015","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.lpm.2015.07.005_bib0480","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.thromres.2013.05.028","article-title":"Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study","volume":"132","author":"Le Moigne","year":"2013","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.lpm.2015.07.005_bib0485","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","article-title":"Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)","volume":"10","author":"Tosetto","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.lpm.2015.07.005_bib0490","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.thromres.2014.10.030","article-title":"Tinzaparin and VKA use in patients with cancer associated venous thromboembolism: a retrospective cohort study","volume":"135","author":"Noel-Savina","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.lpm.2015.07.005_bib0495","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMra010902","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"345","author":"Fedullo","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0500","doi-asserted-by":"crossref","first-page":"g4387","DOI":"10.1136\/bmj.g4387","article-title":"Diagnosis and management of heritable thrombophilias","volume":"349","author":"MacCallum","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2015.07.005_bib0505","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1182\/asheducation-2011.1.150","article-title":"Is thrombophilia testing useful?","volume":"2011","author":"Middeldorp","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.lpm.2015.07.005_bib0510","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.293.19.2352","article-title":"Thrombophilia, clinical factors, and recurrent venous thrombotic events","volume":"293","author":"Christiansen","year":"2005","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.lpm.2015.07.005_bib0515","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1182\/blood-2008-06-163279","article-title":"Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial","volume":"112","author":"Kearon","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2015.07.005_bib0520","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","article-title":"Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy","volume":"104","author":"Schulman","year":"1998","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.lpm.2015.07.005_bib0525","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa035422","article-title":"Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism","volume":"349","author":"Kearon","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.lpm.2015.07.005_bib0530","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.thromres.2015.03.010","article-title":"Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies","volume":"135","author":"Di Minno","year":"2015","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.lpm.2015.07.005_bib0535","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MOH.0b013e328356745b","article-title":"Influence of hereditary or acquired thrombophilias on the treatment of venous thromboembolism","volume":"19","author":"Kearon","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.lpm.2015.07.005_bib0540","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199702063360601","article-title":"The duration of oral anticoagulant therapy after a second episode of venous thromboembolism","volume":"336","author":"Schulman","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0545","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199802123380701","article-title":"A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis","volume":"338","author":"Decousus","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0550","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa035029","article-title":"Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism","volume":"348","author":"Ridker","year":"2003","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.lpm.2015.07.005_bib0555","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"Crowther","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0560","first-page":"515","article-title":"Normalization rates of compression ultrasonography in patients with a first episode of deep-vein thrombosis of the lower limbs: association with recurrence and new thrombosis","volume":"87","author":"Piovella","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.lpm.2015.07.005_bib0565","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-137-12-200212170-00008","article-title":"Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism","volume":"137","author":"Prandoni","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0570","first-page":"734","article-title":"Post-thrombotic syndrome, recurrence, and death10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months","volume":"4","author":"Schulman","year":"2006","journal-title":"JTH"},{"key":"10.1016\/j.lpm.2015.07.005_bib0575","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-2796.2000.00662.x","article-title":"The risk of ipsilateral versus contralateral recurrent deep-vein thrombosis in the leg. The DURAC Trial Study Group","volume":"247","author":"Lindmarker","year":"2000","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.lpm.2015.07.005_bib0580","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1538-7836.2011.04254.x","article-title":"Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep-vein thrombosis: a systematic review and meta-analysis","volume":"9","author":"Carrier","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.lpm.2015.07.005_bib0585","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-0037-1613230","article-title":"Comparison of outcomes after hospitalization for deep-vein thrombosis or pulmonary embolism","volume":"88","author":"Murin","year":"2002","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.lpm.2015.07.005_bib0590","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-152-9-201005040-00008","article-title":"Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism","volume":"152","author":"Carrier","year":"2010","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.lpm.2015.07.005_bib0595","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1111\/j.1538-7836.2010.04022.x","article-title":"Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis","volume":"8","author":"Baglin","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.lpm.2015.07.005_bib0600","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1056\/NEJMoa054444","article-title":"D-dimer testing to determine the duration of anticoagulation therapy","volume":"355","author":"Palareti","year":"2006","journal-title":"NEJM"},{"issue":"8","key":"10.1016\/j.lpm.2015.07.005_bib0605","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7326\/0003-4819-153-8-201010190-00009","article-title":"Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism","volume":"153","author":"Douketis","year":"2010","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.lpm.2015.07.005_bib0610","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1503\/cmaj.080493","article-title":"Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy","volume":"179","author":"Rodger","year":"2008","journal-title":"CMAJ"},{"issue":"14","key":"10.1016\/j.lpm.2015.07.005_bib0615","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","article-title":"Risk assessment of recurrence in patients with unprovoked deep-vein thrombosis or pulmonary embolism: the Vienna prediction model","volume":"121","author":"Eichinger","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2015.07.005_bib0620","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMoa032959","article-title":"The risk of recurrent venous thromboembolism in men and in women","volume":"350","author":"Kyrle","year":"2004","journal-title":"NEJM"},{"key":"10.1016\/j.lpm.2015.07.005_bib0625","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(06)69110-1","article-title":"Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis","volume":"368","author":"McRae","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2015.07.005_bib0630","first-page":"2199","article-title":"Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial","volume":"4","author":"Cushman","year":"2006","journal-title":"JTH"},{"key":"10.1016\/j.lpm.2015.07.005_bib0635","doi-asserted-by":"crossref","first-page":"d813","DOI":"10.1136\/bmj.d813","article-title":"Risk of recurrence after venous thromboembolism in men and women: patient-level meta-analysis","volume":"342","author":"Douketis","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2015.07.005_bib0640","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archinte.159.5.445","article-title":"Predictors of survival after deep-vein thrombosis and pulmonary embolism: a population-based, cohort study","volume":"159","author":"Heit","year":"1999","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.lpm.2015.07.005_bib0645","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3324\/haematol.10516","article-title":"The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep-vein thrombosis or pulmonary embolism. A prospective cohort study in 1626 patients","volume":"92","author":"Prandoni","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.lpm.2015.07.005_bib0650","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.104.512834","article-title":"Eight-Year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism","volume":"112","author":"The Prepic Study Group","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2015.07.005_bib0655","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","article-title":"Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin","volume":"105","author":"Beyth","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0660","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-133-9-200011070-00010","article-title":"A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial","volume":"133","author":"Beyth","year":"2000","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.lpm.2015.07.005_bib0665","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.lpm.2015.07.005_bib0670","doi-asserted-by":"crossref","first-page":"893","DOI":"10.7326\/0003-4819-139-11-200312020-00007","article-title":"Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis","volume":"139","author":"Linkins","year":"2003","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.lpm.2015.07.005_bib0675","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jth.12485","article-title":"Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis","volume":"12","author":"van der Hulle","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.lpm.2015.07.005_bib0680","series-title":"The risk of venous thrombosis and its transmission: medical progress and loss of body image \u201cOf bodies and symptoms, Anthropological perspectives on their social and medical treatment\u201d","first-page":"151","author":"Haxaire","year":"2011"},{"issue":"8","key":"10.1016\/j.lpm.2015.07.005_bib0685","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0690","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"EINSTEIN Investigators","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.lpm.2015.07.005_bib0695","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1113697","article-title":"Extended use of dabigatran, warfarin, or placebo in venous thromboembolism","volume":"368","author":"Schulman","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.07.005_bib0700","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2141.2006.05960.x","article-title":"Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism","volume":"133","author":"W\u00e5hlander","year":"2006","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1016\/j.lpm.2015.07.005_bib0705","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"Becattini","year":"2012","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.lpm.2015.07.005_bib0355","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1016\/j.lpm.2015.09.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000}}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498215003371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498215003371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T03:52:28Z","timestamp":1567050748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498215003371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":71,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0755498215003371"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2015.07.005","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dur\u00e9e optimale du traitement anticoagulant au d\u00e9cours d\u2019une embolie pulmonaire","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2015.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}